CN107595774A - 一种自乳化纳米复乳及其制备方法和应用 - Google Patents
一种自乳化纳米复乳及其制备方法和应用 Download PDFInfo
- Publication number
- CN107595774A CN107595774A CN201711000507.7A CN201711000507A CN107595774A CN 107595774 A CN107595774 A CN 107595774A CN 201711000507 A CN201711000507 A CN 201711000507A CN 107595774 A CN107595774 A CN 107595774A
- Authority
- CN
- China
- Prior art keywords
- emulsifying
- self
- mixed
- emulsion
- nanometer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 129
- 238000002360 preparation method Methods 0.000 title claims abstract description 63
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 55
- 210000003022 colostrum Anatomy 0.000 claims abstract description 46
- 235000021277 colostrum Nutrition 0.000 claims abstract description 46
- 239000012071 phase Substances 0.000 claims abstract description 34
- 239000004094 surface-active agent Substances 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 239000008346 aqueous phase Substances 0.000 claims abstract description 18
- 238000013019 agitation Methods 0.000 claims abstract description 14
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 40
- 238000003756 stirring Methods 0.000 claims description 30
- 239000003921 oil Substances 0.000 claims description 28
- 235000019198 oils Nutrition 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000012153 distilled water Substances 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 13
- 235000010445 lecithin Nutrition 0.000 claims description 13
- 239000000787 lecithin Substances 0.000 claims description 13
- 229940067606 lecithin Drugs 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000004945 emulsification Methods 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 8
- 229960000502 poloxamer Drugs 0.000 claims description 8
- 229920001983 poloxamer Polymers 0.000 claims description 8
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 7
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 7
- 238000013459 approach Methods 0.000 claims description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000003549 soybean oil Substances 0.000 claims description 7
- 235000012424 soybean oil Nutrition 0.000 claims description 7
- 229940031439 squalene Drugs 0.000 claims description 7
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 7
- 239000008215 water for injection Substances 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 5
- 210000004400 mucous membrane Anatomy 0.000 claims description 5
- 235000010199 sorbic acid Nutrition 0.000 claims description 5
- 239000004334 sorbic acid Substances 0.000 claims description 5
- 229940075582 sorbic acid Drugs 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- 239000002953 phosphate buffered saline Substances 0.000 claims description 2
- 241000165940 Houjia Species 0.000 claims 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 1
- 239000007957 coemulsifier Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 235000013772 propylene glycol Nutrition 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000010792 warming Methods 0.000 abstract description 4
- 239000000499 gel Substances 0.000 description 81
- 108020004459 Small interfering RNA Proteins 0.000 description 46
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 26
- 108020004707 nucleic acids Proteins 0.000 description 23
- 150000007523 nucleic acids Chemical class 0.000 description 23
- 102000039446 nucleic acids Human genes 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 23
- 239000007788 liquid Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- 101100248253 Arabidopsis thaliana RH40 gene Proteins 0.000 description 17
- 238000001890 transfection Methods 0.000 description 17
- 230000001804 emulsifying effect Effects 0.000 description 16
- 230000014509 gene expression Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 239000004530 micro-emulsion Substances 0.000 description 13
- 238000012384 transportation and delivery Methods 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 9
- 239000012096 transfection reagent Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 238000001215 fluorescent labelling Methods 0.000 description 8
- 235000014571 nuts Nutrition 0.000 description 8
- 210000001215 vagina Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000012377 drug delivery Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000012097 Lipofectamine 2000 Substances 0.000 description 6
- 102000006382 Ribonucleases Human genes 0.000 description 6
- 108010083644 Ribonucleases Proteins 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000007908 nanoemulsion Substances 0.000 description 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000005352 clarification Methods 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 108091030071 RNAI Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000004064 cosurfactant Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000001647 drug administration Methods 0.000 description 4
- 230000009368 gene silencing by RNA Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 230000010494 opalescence Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000003308 immunostimulating effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000012202 endocytosis Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000006674 lysosomal degradation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000013441 quality evaluation Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- 101100478064 Dictyostelium discoideum pspB gene Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 231100000294 dose-dependent toxicity Toxicity 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000003050 experimental design method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000019580 granularity Nutrition 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000008307 w/o/w-emulsion Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000000733 zeta-potential measurement Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711000507.7A CN107595774B (zh) | 2017-10-24 | 2017-10-24 | 一种自乳化纳米复乳及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711000507.7A CN107595774B (zh) | 2017-10-24 | 2017-10-24 | 一种自乳化纳米复乳及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107595774A true CN107595774A (zh) | 2018-01-19 |
CN107595774B CN107595774B (zh) | 2020-01-31 |
Family
ID=61079576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711000507.7A Active CN107595774B (zh) | 2017-10-24 | 2017-10-24 | 一种自乳化纳米复乳及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107595774B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109528651A (zh) * | 2018-11-20 | 2019-03-29 | 江苏远恒药业有限公司 | 一种含多肽类药物的w/o/w型复合纳米乳凝胶透皮制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037045A2 (en) * | 1998-12-22 | 2000-06-29 | Maine Biological Laboratories, Inc. | Stabilized water-in-oil-in-water antigen delivery system |
CN1307903A (zh) * | 1999-11-05 | 2001-08-15 | 日本油脂株式会社 | 油佐剂疫苗 |
CN102805726A (zh) * | 2012-03-29 | 2012-12-05 | 中国人民解放军第二军医大学 | siRNA微乳载体及其制备方法 |
CN102885784A (zh) * | 2012-09-26 | 2013-01-23 | 复旦大学附属金山医院 | 纳米颗粒混悬液包油-油包纳米药物制备微球的方法 |
-
2017
- 2017-10-24 CN CN201711000507.7A patent/CN107595774B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037045A2 (en) * | 1998-12-22 | 2000-06-29 | Maine Biological Laboratories, Inc. | Stabilized water-in-oil-in-water antigen delivery system |
CN1307903A (zh) * | 1999-11-05 | 2001-08-15 | 日本油脂株式会社 | 油佐剂疫苗 |
CN102805726A (zh) * | 2012-03-29 | 2012-12-05 | 中国人民解放军第二军医大学 | siRNA微乳载体及其制备方法 |
CN102885784A (zh) * | 2012-09-26 | 2013-01-23 | 复旦大学附属金山医院 | 纳米颗粒混悬液包油-油包纳米药物制备微球的方法 |
Non-Patent Citations (1)
Title |
---|
KOEN RAEMDONCK,ET AL: "Biodegradable Dextran Nanogels for RNA Interference:Focusing on Endosomal Escape and Intracellular siRNA Delivery", 《ADV.FUNCT.MATER》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109528651A (zh) * | 2018-11-20 | 2019-03-29 | 江苏远恒药业有限公司 | 一种含多肽类药物的w/o/w型复合纳米乳凝胶透皮制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107595774B (zh) | 2020-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Choradiya et al. | A comprehensive review on nanoemulsion as an ophthalmic drug delivery system | |
Muzaffar et al. | Review on microemulsion as futuristic drug delivery | |
Abdel-Rashid et al. | Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide | |
CN103906504B (zh) | 制备用于药物递送的脂质纳米颗粒的方法 | |
Hagigit et al. | Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye | |
CN106420610B (zh) | 一种离子液体微乳及其应用 | |
Lin et al. | Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes | |
Baghbani et al. | Formulation design, preparation and characterization of multifunctional alginate stabilized nanodroplets | |
Hu et al. | Rhein laden pH-responsive polymeric nanoparticles for treatment of osteoarthritis | |
Shang et al. | pH-and ultrasound-responsive paclitaxel-loaded carboxymethyl chitosan nanodroplets for combined imaging and synergistic chemoradiotherapy | |
Grant-Serroukh et al. | Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo | |
CN107157953A (zh) | 一种补骨脂素聚合物纳米粒制剂以及制备方法 | |
Roques et al. | Comparison of toxicity and transfection efficiency of amphiphilic block copolymers and polycationic polymers in striated muscles | |
CN109125306B (zh) | 靶向肝癌的自噬siRNA-Fingolimod共递送脂质纳米颗粒 | |
CN1985851A (zh) | 含有蟾酥提取物的脂质微球注射液及其制备方法 | |
CN102846552B (zh) | 多西他赛脂质纳米粒的制备和应用 | |
CN107595774A (zh) | 一种自乳化纳米复乳及其制备方法和应用 | |
Wu et al. | Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure | |
CN106074383B (zh) | 孕激素药物脂微球注射液及其制备方法 | |
Karagöz et al. | Preparation and characterization of non-viral gene delivery systems with pEGFP-C1 Plasmid DNA | |
Wang et al. | Preparation and optimization formulation of zedoary turmeric oil nanoemulsion based thermo-sensitive gel for improved application in ophthalmology | |
CN108721215A (zh) | 艾氟康唑微乳组合物 | |
Keservani et al. | Nanodispersions for drug delivery | |
CN105796497B (zh) | 一种高贮藏稳定性薏苡仁油温敏脂质体的制备方法 | |
Boudier et al. | Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240508 Address after: 511400 building 28, Chuangzhi, 63 Chuangqi Road, Shilou Town, Panyu District, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU NALI BIOTECHNOLOGY CO.,LTD. Country or region after: China Address before: Hubei Provincial Key Laboratory of Wudang Traditional Chinese Medicine Research, No. 30 Renmin South Road, Maojian District, Shiyan City, Hubei Province, 442000 Patentee before: HUBEI University OF MEDICINE Country or region before: China |